Skip to main content
OpenTrials

Clinical trial condition

Immunoproliferative Disorders

Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,023 public trials 2,029 recruiting studies
Refine in advanced search Browse all conditions

Immunoproliferative Disorders trial results

Completed

CREATE: Cross-tumoral Phase 2 With Crizotinib

NCT01524926

Conditions
Granuloma, Granuloma, Plasma Cell, Hemic and Lymphatic Diseases, +27 more
Locations
  • Hôpitaux Universitaires Bordet-Erasme - Institut Jules Bordet Brussels, Belgium
  • U.Z. Gasthuisberg Leuven, Belgium
  • Institut Bergonie Bordeaux, France
  • Centre Georges-Francois-Leclerc Dijon, France
View all 25 locations
View Trial Details
Completed

A Study of Subcutaneous Delivery of JNJ-54767414 in Chinese Participants With Multiple Myeloma

NCT04121260

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Peking University Third Hospital Beijing, China
  • The Third Xiangya Hospital, Central South University Changsha, China
  • Nanfang Hospital Guangzhou, China
  • Zhongda Hospital,Southeast University Nanjing, China
View Trial Details
Completed

Nivolumab Maintenance Therapy After Autologous Stem Cell Transplant in Hodgkin Lymphoma Pts at Relapse/Progression Risk

NCT03436862

Conditions
Hematologic Diseases, Hematologic Neoplasms, Hemic and Lymphatic Diseases, +10 more
Locations
  • Colorado Blood Cancer Institute Denver, Colorado, United States
  • HCA Midwest Kansas City, Missouri, United States
  • Tennessee Oncology Nashville, Tennessee, United States
  • St. David's South Austin Medical Center Austin, Texas, United States
View Trial Details

Related conditions